Principal Investigator
Ihtsham Haq
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230279
Clinical Trial Summary
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinsons Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Lucila Hernandez
Phone Number
+1 (305) 2431160
Email
lmh245@miami.edu